summary
Introduced
04/20/2022
04/20/2022
In Committee
10/24/2022
10/24/2022
Crossed Over
06/20/2022
06/20/2022
Passed
10/26/2022
10/26/2022
Dead
Signed/Enacted/Adopted
11/03/2022
11/03/2022
Introduced Session
2021-2022 Regular Session
Bill Summary
Amending the act of April 14, 1972 (P.L.233, No.64), entitled "An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act," further providing for drug overdose medication.
AI Summary
This bill amends the Controlled Substance, Drug, Device and Cosmetic Act to further provide for drug overdose medication. Specifically, it requires the Department of Health to amend the emergency medical services provider scope of practice to include administration of opioid antagonists, such as naloxone. It also allows law enforcement agencies and fire departments to obtain opioid antagonists and authorize trained personnel to administer them. The bill provides immunity from criminal and civil liability for health care professionals who prescribe or dispense opioid antagonists, as well as for those who administer them in good faith. The term "opioid antagonist" is defined as a drug or device approved by the FDA for emergency reversal of known or suspected opioid overdose.
Committee Categories
Budget and Finance, Justice
Sponsors (14)
Christopher Quinn (R)*,
Joe Ciresi (D),
Dan Frankel (D),
Mark Gillen (R),
Nancy Guenst (D),
Carol Hill-Evans (D),
Napoleon Nelson (D),
F. Todd Polinchock (R),
David Rowe (R),
Christina Sappey (D),
Jim Struzzi (R),
Joseph Webster (D),
Craig Williams (R),
Dave Zimmerman (R),
Last Action
Act No. 135 of 2022 (on 11/03/2022)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...